RxDoctor Payments DataLook up a doctor →

Patricio Espinosa, MD

Neuromusculoskeletal Medicine & OMM · Boca Raton, FLNPI 1861697948

Payments from drug & device makers

$1,368,112in general payments, 2019–2025

Across 2,281 payments — averaging $599.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$791K
  • Biogen$148K
  • Ipsen Pharma SAS$107K
  • AbbVie$50K
  • EMD Serono, Inc.$40K
  • Argenx US, Inc.$34K
  • plus $195K from 54 others
$8,800in research payments, 2019–2025

Across 1 payment — averaging $8800.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$9K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis136$791,202
Biogen78$148,255
Ipsen Pharma SAS86$106,837
AbbVie(2 entities)228$49,919
EMD Serono, Inc.155$40,483
Argenx US, Inc.60$34,213
Biohaven Pharmaceuticals, Inc.44$29,932
Livanova USA, Inc.30$27,530
Sanofi68$23,408
Pfizer78$20,071
UCB SA2$11,082
Amgen(2 entities)66$8,215
Biohaven Pharmaceutical Holding Company Ltd.25$7,978
Roche Products Limited2$7,073
Sunovion Pharmaceuticals Inc.19$6,700
Ipsen Biopharmaceuticals, Inc5$5,852
AstraZeneca(2 entities)71$4,745
Abbott49$4,441
Grifols USA, LLC22$4,371
Axsome Therapeutics, Inc.11$3,961
Eisai Inc.80$3,756
UCB, Inc.107$3,122
Aquestive Therapeutics, Inc.10$2,218
Lilly USA, LLC37$1,598
Teva Pharmaceuticals USA, Inc.58$1,238
MDD US Operations, LLC38$1,086
Genentech USA, Inc.45$1,035
Merz Pharmaceuticals, LLC29$1,012
Takeda Pharmaceuticals U.S.A., Inc.34$1,011
Neurelis, Inc.47$987
Hyperfine Operations, Inc.3$883
CSL Behring42$842
Johnson & Johnson(2 entities)35$831
Neurocrine Biosciences, Inc.36$780
Amneal Pharmaceuticals LLC49$747
Acadia Pharmaceuticals Inc64$684
Harmony Biosciences LLC17$631
Lundbeck LLC21$626
Corium, LLC8$547
Alnylam Pharmaceuticals Inc.20$543
Medtronic(2 entities)8$543
Bristol Myers Squibb16$478
E.r. Squibb & Sons, L.L.C.8$474
Octapharma USA, Inc.12$436
Jazz Pharmaceuticals Inc.9$363
Scilex Pharmaceuticals Inc.28$348
SK Life Science, Inc.12$299
Tanabe Pharma America, Inc.13$290
Kyowa Kirin, Inc.9$253
ANI Pharmaceuticals, Inc.9$252
Vertex6$250
TG Therapeutics, Inc.5$246
Almatica Pharma LLC13$246
Otsuka America Pharmaceutical, Inc.9$244
Catalyst Pharmaceuticals, Inc.9$205
Acorda Therapeutics, Inc10$200
Mallinckrodt Hospital Products Inc.6$190
C2n Diagnostics, LLC1$166
Akcea Therapeutics, Inc.3$157
Janssen Scientific Affairs, LLC1$131

How this compares

$1,368,112 in reported general payments places this provider in the 95th percentile of 41 neuromusculoskeletal medicine & omm providers in Florida.

See all neuromusculoskeletal medicine & omm providers in Florida →

Medicare billing

Part B allowed, 2024
$1,160,000
Medicare patients
1,788
Services billed
75,523

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neuromusculoskeletal medicine & omm in Boca Raton

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →